Mustang Bio, Inc. (MBIO): Price and Financial Metrics

Mustang Bio, Inc. (MBIO): $0.21

0.01 (-5.30%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add MBIO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#115 of 339

in industry

MBIO Price/Volume Stats

Current price $0.21 52-week high $1.68
Prev. close $0.22 52-week low $0.13
Day low $0.21 Volume 407,100
Day high $0.22 Avg. volume 8,999,149
50-day MA $0.24 Dividend yield N/A
200-day MA $0.49 Market Cap 9.99M

MBIO Stock Price Chart Interactive Chart >


Mustang Bio, Inc. (MBIO) Company Bio


Mustang Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products based on the chimeric antigen receptor engineered T cell technology. Its lead programs include MB-101 for the treatment of brain cancer that is in Phase I trials; and MB-102, a therapeutic agent in acute myeloid leukemia, which is in Phase I trials. The company was founded in 2015 and is based in New York, New York. Mustang Bio Inc. is a subsidiary of Fortress Biotech, Inc.


MBIO Latest News Stream


Event/Time News Detail
Loading, please wait...

MBIO Latest Social Stream


Loading social stream, please wait...

View Full MBIO Social Stream

MBIO Price Returns

1-mo -25.56%
3-mo -43.85%
6-mo 0.05%
1-year -86.54%
3-year -99.34%
5-year -99.50%
YTD -84.44%
2023 -77.21%
2022 -76.21%
2021 -56.14%
2020 -7.23%
2019 38.78%

Continue Researching MBIO

Want to see what other sources are saying about Mustang Bio Inc's financials and stock price? Try the links below:

Mustang Bio Inc (MBIO) Stock Price | Nasdaq
Mustang Bio Inc (MBIO) Stock Quote, History and News - Yahoo Finance
Mustang Bio Inc (MBIO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!